Verified Nov 2026
Batteries & E-Mobility
·

Cambridge, England
·
Since 2003
Jazz Pharmaceuticals plc is a biopharmaceutical company founded in 2003 and headquartered in Dublin, Ireland, with 1,000–5,000 employees and estimated revenue of $1–5 billion. The company develops medicines for rare and serious diseases, particularly in neuroscience and oncology. In September 2026, Jazz completed the acquisition of Actio Biosciences to expand its pipeline capabilities.
GW Pharmaceuticals plc at a glance
Revenue
$1-5B
Est. band
Employees
1,000-5,000
Founded
2003
Headquarters
Cambridge, England
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Jazz Pharmaceuticals plc is a biopharmaceutical company founded in 2003 and headquartered in Dublin, Ireland, with 1,000–5,000 employees and estimated revenue of $1–5 billion. The company develops medicines for rare and serious diseases, particularly in neuroscience and oncology. In September 2026, Jazz completed the acquisition of Actio Biosciences to expand its pipeline capabilities.
At a glance
Attribute | Detail |
|---|---|
Founded | 2003 |
Headquarters | Cambridge, England |
Employees | 1,000-5,000 |
Revenue | $1-5B (estimated) |
Primary capability | Batteries & E-Mobility |
What GW Pharmaceuticals plc makes
The company markets approved therapies including Xywav and Xyrem for narcolepsy, Epidiolex for severe epilepsy, and Zepzelca for metastatic lung cancer.
Latest developments
2026-11-02 — Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results | Jazz Pharmaceuticals plc (jazzpharma.com)
2026-10-23 — Press Release Archive | Jazz Pharmaceuticals plc (jazzpharma.com)
2026-09-15 — Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences | Jazz Pharmaceuticals plc (jazzpharma.com)
2026-02-24 — Jazz Pharmaceuticals (JAZZ) Stock-Based Compensation (2015-2025 10-K) | edgar.tools (edgar.tools)
2025-08-20 — Jazz Pharmaceuticals Enters Exclusive Licensing Agreement with Saniona to Develop and Commercialize SAN2355 | Jazz Pharmaceuticals plc (jazzpharma.com)
2025-03-05 — Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio | Jazz Pharmaceuticals plc (jazzpharma.com)
Company details
Jazz Pharmaceuticals operates manufacturing facilities in Ireland, England, and Italy, and maintains significant corporate presences in the United States and the United Kingdom. GW Pharmaceuticals plc was founded in 2003, has an estimated 1,000-5,000 employees, and is headquartered in Cambridge, England.
Frequently asked questions
What does GW Pharmaceuticals plc make?
Jazz Pharmaceuticals plc is a biopharmaceutical company founded in 2003 and headquartered in Dublin, Ireland, with 1,000–5,000 employees and estimated revenue of $1–5 billion. The company develops medicines for rare and serious diseases, particularly in neuroscience and oncology. In September 2026, Jazz completed the acquisition of Actio Biosciences to expand its pipeline capabilities.
Where is GW Pharmaceuticals plc headquartered?
GW Pharmaceuticals plc is headquartered in Cambridge, England (Chivers Way, Cambridge, England, CB24 9).
When was GW Pharmaceuticals plc founded?
GW Pharmaceuticals plc was founded in 2003.
How big is GW Pharmaceuticals plc?
GW Pharmaceuticals plc has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
